Page last updated: 2024-09-05

bd 1047 and Bone Cancer

bd 1047 has been researched along with Bone Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Han, Y; Hu, X; Liu, Y; Song, C; Wang, C; Zhu, S	1

Other Studies

1 other study(ies) available for bd 1047 and Bone Cancer

Article	Year
Sigma-1 Receptor Antagonist BD1047 Reduces Mechanical Allodynia in a Rat Model of Bone Cancer Pain through the Inhibition of Spinal NR1 Phosphorylation and Microglia Activation. Mediators of inflammation, 2015, Volume: 2015 Topics: Animals; Bone Neoplasms; Disease Models, Animal; Ethylenediamines; Extracellular Signal-Regulated MAP Kinases; Female; Hyperalgesia; Microglia; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Receptors, sigma; Sigma-1 Receptor; Spinal Cord	2015

Article

Year

Sigma-1 Receptor Antagonist BD1047 Reduces Mechanical Allodynia in a Rat Model of Bone Cancer Pain through the Inhibition of Spinal NR1 Phosphorylation and Microglia Activation.

Mediators of inflammation, 2015, Volume: 2015

Topics: Animals; Bone Neoplasms; Disease Models, Animal; Ethylenediamines; Extracellular Signal-Regulated MAP Kinases; Female; Hyperalgesia; Microglia; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Receptors, sigma; Sigma-1 Receptor; Spinal Cord

2015